AC Immune SA
EPFL Innovation Park, Building B
1015 Lausanne Switzerland
Website: www.acimmune.com
Email: info@acimmune.com
Phone: 011-41-21-693-91-21
Fax: 011-41-21-693-91-20

Number of Employees: 51-200

Revenue: $20,255,000 CHF

Swiss-based biopharmaceutical company focused on neurodegenerative diseases with four product candidates in clinical trials. The Company designs, discovers and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. AC Immune's two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as Alzheimer's disease.

General Management
R&D/Regulatory
Name Title Phone Email
Andrea Pfeifer, PhD Chief Executive Officer andrea.pfeifer@acimmune.com
Jorg Hornstein Chief Financial Officer
Jean-Fabien Monin Chief Administrative Officer jean-fabien.monin@acimmune.com
Andreas Muhs, PhD Chief Scientific Officer andreas.muhs@acimmune.com
General Management
Andrea Pfeifer, PhD Chief Executive Officer andrea.pfeifer@acimmune.com
Jorg Hornstein Chief Financial Officer
Jean-Fabien Monin Chief Administrative Officer jean-fabien.monin@acimmune.com
R&D/Regulatory
Andreas Muhs, PhD Chief Scientific Officer andreas.muhs@acimmune.com